Upcoming updates
for 2026-2027
Use of Long-Acting Injectable Antipsychotics in Schizophrenia – Interview
Quick Take Vol. 85
Tricyclic Antidepressants in Psychiatry
Management of Psychotropic-Induced Sexual Dysfunction
Nutritional Psychiatry – Interview
Antidepressant-Induced Excessive Sweating
Quick Take Vol. 86
Pharmacotherapy of Alcohol Use Disorder – Interview
Posttraumatic Stress Disorder Psychopharmacology Algorithm (Update)
Side Effects of Antidepressants Part 5 (Hyperprolactinemia)
Quick Take Vol. 87
Antidepressant Withdrawal Effects and Safe Deprescribing – Interview
Prescribing for mental health conditions in patients with physical illness
Cardiac Effects of Antidepressants: A Clinical Guide
Quick Take Vol. 88
Ophthalmologic Effects of Antidepressants: A Clinical Guide
Treatment-Resistant Anxiety Disorders: Focus on GAD, PD, and SAD
Metabolic Psychiatry
Lamotrigine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 89
Nutraceuticals and Phytoceuticals for Mood and Anxiety Disorders
Ketamine and Esketamine
Valproate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 90
Pharmacotherapies for Stimulant Use Disorder (Update)
Pharmacotherapy of treatment-resistant depression – Interview
Lithium Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 91
Buspirone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Pharmacotherapy for Cannabis Use Disorder
Mood and Anxiety Disorders During Perimenopause – Interview
Quick Take Vol. 92
Atomoxetine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Updates on Geriatric Psychopharmacology – Interview
Pharmacological Management of Primary Insomnia
Methylphenidate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 93
Psychotropic-Induced Movement Disorders and Cognitive Side Effects (Update) – Interview
Switching Antipsychotics in Clinical Practice 2026 update
Amphetamines Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 94
Pharmacotherapy Bipolar Depression: Strategies for Everyday Management – Interview
Drug-Drug Interactions in Psychopharmacology.
ADHD Medications: A Comprehensive Formulations Guide
Quick Take Vol. 95
Brexpiprazole Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Treatment-Resistant Obsessive-Compulsive Disorder (Update) – Interview
Quick Take Vol. 96
Cariprazine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
CME Information
Physicians – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
Physician assistants – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.